Roberto De Luca

18PUBLICATIONS
54CO-AUTHORS
Clinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsCharacterisation of biological macromoleculesInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Nov 11, 2025
Generation and characterization of novel high-affinity fully human antibodies targeting prostate-specific membrane antigen and prostatic acid phosphatase.

Claudia Comacchio, Stefanie K Pfister, Domenico Ravazza

|Sep 30, 2025
Immunocompetent Mouse Models of Cancer Reveal the Superiority of Cellular Targets over Stromal Targets for the Development of Anticancer Bispecific Antibodies.

Stefanie K Pfister, Frauke Seehusen, Francesco Prisco

|Sep 18, 2024
Efficient combinatorial adaptor-mediated targeting of acute myeloid leukemia with CAR T-cells.

Laura Volta, Renier Myburgh, Christian Pellegrino

|Sep 03, 2024
Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy.

Eleonora Prodi, Dario Neri, Roberto De Luca

|Aug 23, 2024
Tripokin: A multi-specific immunocytokine for cancer immunotherapy.

Eleonora Prodi, Riccardo Corbellari, Lorenzo Ghezzi

|Aug 14, 2024
An IL-7 fusion protein targeting EDA fibronectin upregulates TCF1 on CD8+ T-cells, preferentially accumulates to neoplastic lesions, and boosts PD-1 blockade.

Cesare Di Nitto, Domenico Ravazza, Ettore Gilardoni

Pageof 3

Frequent Collaborators

7 joint publications

Dario Neri

6 joint publications

Tobias Weiss

5 joint publications

Christian Pellegrino

4 joint publications

Emanuele Puca